Highlights from BSH 2019

Written by Alex Burton | 1 May 2019 | All Medical News

The 2019 annual meeting of the BSH showcased the best UK research with over 36 sessions covering a range of important issues related to the treatment of haematological disease. In this video, Professor Simon Rule (Plymouth, UK) and Dr Chris Fox (Nottingham, UK) discuss the importance of BSH annual meeting, and the advances made in the treatment of diseases such as lymphoma.

Interviewer: Hannah Chatfield. Article: Maria Dalby.

Highlights from BSH 2019

Latest Stories

Liminal BioSciences announces FDA approval for its BLA of Ryplazim to treat patients with plasminogen deficiency type 1

Simple diagnostic tool predicts individual risk of Alzheimer’s

Janssen presents results of first head-to-head study of biologic therapies in patients with moderate to severe Crohn’s disease

Testosterone therapy may reduce non-alcoholic fatty liver disease in obese

Highlights from BSH 2019

Latest Stories

Liminal BioSciences announces FDA approval for its BLA of Ryplazim to treat patients with plasminogen deficiency type 1

Simple diagnostic tool predicts individual risk of Alzheimer’s

Janssen presents results of first head-to-head study of biologic therapies in patients with moderate to severe Crohn’s disease

Testosterone therapy may reduce non-alcoholic fatty liver disease in obese

Register for our mailing list

Follow Us